Tumor cells transform fibroblasts into cancer-associated fibroblasts, which have an important immunosuppressive activity on which growth, invasion, and metastasis depend. These activated fibroblasts ...

The firm is paying €7 million to add fibroblast activation protein-targeting assets to its pipeline, which it will initially develop for bladder cancer.

These shares are missing out on the good times on Tuesday. But why? The post Why Elders, KMD, Lovisa, and Telix shares are ...

Pancreatic cancer (PC) presents substantial diagnostic challenges due to its aggressive nature and lack of early symptoms, ...

This research provides a quantitative analysis of the fibroblast-to-myofibroblast transition (FMT), a critical process in ...

Cancer-associated fibroblast subtypes modulate the tumor immune microenvironment and are associated with the aggressiveness ...

Radiopharmaceutical company Telix Pharmaceuticals Ltd. has inked a deal worth up to AU$264 million (US$171 million) to license and develop next-generation radiopharma imaging and therapy technology ...

Astrazeneca plc has developed a potent oral fibroblast activation protein (FAP) inhibitor, AZD-2389, that avoids the cleavage of FGF21 and α2-AP. AZD-2389 was tested in cynomolgus monkeys with ...

Molecular Partners AG (OTCMKTS:MLLCF – Get Free Report)’s stock price dropped 9.4% on Monday . The stock traded as low as $4.53 and last traded at $4.53. Approximately 300 shares were traded during ...

Broadly, these enzymes fall into 5 categories based on substrate specificity: (1) interstitial collagenases (MMP-1, -8, -13); (2) gelatinases (MMP-2,-9) and fibroblast activation protein ...